4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-22-007489
Options or other derivatives
- Chief Financial Officer acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Broadfoot Jill Marie Chief Financial Officer | 2022-02-03 | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | D | ||
| Broadfoot Jill Marie Chief Financial Officer | 2022-02-03 | Grant or award · Restricted Stock Units | +15,000 | 15,000 | D | ||
Loading xslF345X03/doc4.xml…